DermaVir: a novel topical vaccine for HIV/AIDS.

@article{Lisziewicz2005DermaVirAN,
  title={DermaVir: a novel topical vaccine for HIV/AIDS.},
  author={Julianna Lisziewicz and Jeffrey N Trocio and Lucia Whitman and Georg Varga and Jianqing Xu and Nyasha Bakare and Patrick Erbacher and Cecil Fox and Ruth A. Woodward and Phil Markham and Suresh Kumar Arya and Jean-Paul Behr and Franco Lori},
  journal={The Journal of investigative dermatology},
  year={2005},
  volume={124 1},
  pages={
          160-9
        }
}
Human immunodeficiency virus (HIV) vaccines have the potential to improve antiretroviral drug treatment by inducing cytotoxic killing of HIV-infected cells. Prophylactic vaccines utilize new antigens to initiate immunity; however, in HIV-infected individuals the load of viral antigen is not the limiting factor for the restoration of immune responses. Here we describe a novel immunization strategy with DermaVir that improves viral antigen presentation using dendritic cells (DC). DermaVir… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 36 CITATIONS

Well-defined block copolymers for gene delivery to dendritic cells: probing the effect of polycation chain-length.

  • Journal of controlled release : official journal of the Controlled Release Society
  • 2010
VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

HIV-1 IMMUNE RESPONSES INDUCED BY NATURAL INFECTION OR IMMUNISATION

VIEW 3 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Polyethylenimine-based micro/nanoparticles as vaccine adjuvants

  • International journal of nanomedicine
  • 2017
VIEW 1 EXCERPT
CITES METHODS

Non-viral gene therapy: Gains and challenges of non-invasive administration methods.

  • Journal of controlled release : official journal of the Controlled Release Society
  • 2016
VIEW 1 EXCERPT
CITES BACKGROUND